Post-pandemic Era-Global Axillary Hyperhidrosis Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 247767 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Axillary Hyperhidrosis Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Botulinum ToxinA -Product Introduction and Major Manufacturers
      1.1.2 Glycopyrrolate -Product Introduction and Major Manufacturers
      1.1.3 Glycopyrronium Tosylate -Product Introduction and Major Manufacturers
      1.1.4 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.1.1 China Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.1.2 China Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.2.1 EU Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.2.2 EU Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.3.1 USA Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.3.2 USA Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.4.1 Japan Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.5.1 India Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.5.2 India Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.7.1 South America Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.7.2 South America Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Axillary Hyperhidrosis Drug Status and Prospect (2015-2026)
      2.8.1  Axillary Hyperhidrosis Drug Market Size and Growth Rate (2015-2026)
      2.8.2  Axillary Hyperhidrosis Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Axillary Hyperhidrosis Drug Market Assessment by Segment
    3.1 Global Axillary Hyperhidrosis Drug Capacity and Growth Rate
    3.2 Global Axillary Hyperhidrosis Drug Sales by Type
    3.3 Global Axillary Hyperhidrosis Drug Sales Revenue by Type
    3.4 Global Axillary Hyperhidrosis Drug Consumption by Application
4 Global Axillary Hyperhidrosis Drug Market Assessment by Regions
    4.1 Global Axillary Hyperhidrosis Drug Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Axillary Hyperhidrosis Drug Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Axillary Hyperhidrosis Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Axillary Hyperhidrosis Drug Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Axillary Hyperhidrosis Drug Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Axillary Hyperhidrosis Drug Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Axillary Hyperhidrosis Drug Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Axillary Hyperhidrosis Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Axillary Hyperhidrosis Drug Competitive Analysis
     7.1 Allergan
        7.1.1 Allergan Company Profiles
        7.1.2 Allergan Product Introduction
        7.1.3 Allergan Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Brickell Biotech
        7.2.1 Brickell Biotech Company Profiles
        7.2.2 Brickell Biotech Product Introduction
        7.2.3 Brickell Biotech Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Dermira
        7.3.1 Dermira Company Profiles
        7.3.2 Dermira Product Introduction
        7.3.3 Dermira Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Dr. August Wolff GmbH & Co KG Arzneimittle
        7.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Profiles
        7.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Product Introduction
        7.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Company Profiles
        7.5.2 GlaxoSmithKline Product Introduction
        7.5.3 GlaxoSmithKline Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 TheraVida
        7.6.1 TheraVida Company Profiles
        7.6.2 TheraVida Product Introduction
        7.6.3 TheraVida Axillary Hyperhidrosis Drug Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
8 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Axillary Hyperhidrosis Drug Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Axillary Hyperhidrosis Drug Sales (K Unit) by Type (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Market Share (%) by Type (2019 -2020)
    Table Global Axillary Hyperhidrosis Drug Sales Value (Million USD) by Type (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Value Market Share (%) by Type (2019-2020)
    Table Global Axillary Hyperhidrosis Drug Sales (K Unit) by Application (2015-2026)
    Figure China Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Axillary Hyperhidrosis Drug Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Axillary Hyperhidrosis Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Axillary Hyperhidrosis Drug Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Axillary Hyperhidrosis Drug Sales (Unit) by Type (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Axillary Hyperhidrosis Drug Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Axillary Hyperhidrosis Drug Consumption (Unit) by Application (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Axillary Hyperhidrosis Drug Production (K Unite) by Regions (2015-2020)
    Table Global Axillary Hyperhidrosis Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Production Share by Regions (2019-2020)
    Table Global Axillary Hyperhidrosis Drug Sales (K Unite) by Regions (2015-2020)
    Table Global Axillary Hyperhidrosis Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Share by Regions (2019-2020)
    Table Global Axillary Hyperhidrosis Drug Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Axillary Hyperhidrosis Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Axillary Hyperhidrosis Drug Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Axillary Hyperhidrosis Drug
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Axillary Hyperhidrosis Drug
    Figure Cost Structure of Axillary Hyperhidrosis Drug in 2020
    Table Global Axillary Hyperhidrosis Drug Capacity Share of Manufacturers (2019-2020)
    Figure Global Axillary Hyperhidrosis Drug Capacity Share of Manufacturers (2019-2020)
    Table Global Axillary Hyperhidrosis Drug Sales Market Share of Manufacturers (2019-2020)
    Figure Global Axillary Hyperhidrosis Drug Sales Market Share of Manufacturers (2019-2020)
    Table Global Axillary Hyperhidrosis Drug Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Axillary Hyperhidrosis Drug Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Axillary Hyperhidrosis Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Allergan Profiles
    Table Allergan Axillary Hyperhidrosis Drug Product Introduction
    Table Allergan Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Allergan SWOT Analysis
    Table Brickell Biotech Profiles
    Table Brickell Biotech Axillary Hyperhidrosis Drug Product Introduction
    Table Brickell Biotech Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Brickell Biotech SWOT Analysis
    Table Dermira Profiles
    Table Dermira Axillary Hyperhidrosis Drug Product Introduction
    Table Dermira Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Dermira SWOT Analysis
    Table Dr. August Wolff GmbH & Co KG Arzneimittle Profiles
    Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Introduction
    Table Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Dr. August Wolff GmbH & Co KG Arzneimittle SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Axillary Hyperhidrosis Drug Product Introduction
    Table GlaxoSmithKline Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table TheraVida Profiles
    Table TheraVida Axillary Hyperhidrosis Drug Product Introduction
    Table TheraVida Axillary Hyperhidrosis Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure TheraVida SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Axillary Hyperhidrosis Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Axillary Hyperhidrosis Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Axillary Hyperhidrosis Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports